Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGETS: DYV700 for Acute Gout Flare
NCT04130204Phase 2Completed
- Sponsor
- Dyve Biosciences
- Start
- Feb 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DYV702 in gout, sponsored by Dyve Biosciences. Started Feb 2020; status: completed.
02
Drugs
DYV702
03
Conditions
gout
Beyond the preview
Go deeper on NCT04130204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04130204.